Skip to main content

Table 1 Summary of published clinical trials on XYS in the treatment of MDD

From: Effect of Xiaoyaosan on major depressive disorder

Study ID

Sample size

Diagnostic criteria

Trial design

Course (weeks)

Follow-up (months)

Major outcomes

Intervention

Control

Randomizer

Blindness

Efficacy by HAMD

Clinical efficacy

Side effects

Relapse

Onset time

Xian et al. [6]

60

CCMD-3

XYS decoction

Fluoxetine

Random number table

Single

6

N/A

N/A

N/A

N/A

Zhang et al. [8]

110

Depression Inventory (DI)

Xiaoyao pill

Placebo

Random number table

Double

8

N/A

N/A

↑ (DI)

N/A

N/A

N/A

Feng et al. [7]

58

CCMD-3

XYS decoction

N/A

N/A

N/A

8

N/A

↑(CGI)

N/A

N/A

N/A

  1. CCMD China classification and diagnostic criteria for mental disorder, HAMD Hamilton depression scale, CGI clinical global impression, N/A not available, ↑ significant increase compared with control, ↓ significant decrease compared with control.